000046742 000__ 01183nam\a2200349\i\4500
000046742 001__ 46742
000046742 003__ SzGeWIPO
000046742 005__ 20230510152348.0
000046742 006__ m\\\\e\\\d\\\\\\\\
000046742 008__ 221017s2022\\\\sz\\\\\\\\\\\\000\0\chi\d
000046742 0247_ $$a10.34667/tind.46742$$2doi
000046742 035__ $$aWIPO/PUB/RN2022/14/ZH
000046742 035__ $$a(OCoLC)1348117503
000046742 040__ $$aSzGeWIPO$$bchi$$erda$$cSzGeWIPO$$dCaBNVSL
000046742 041__ $$achi
000046742 24500 $$a产权组织生命科学争议管理和解决的替代性争议解决选项
000046742 264_1 $$aGeneva, Switzerland :$$bWorld Intellectual Property Organization,$$c2022.
000046742 300__ $$a32 pages;$$c[28] cm
000046742 336__ $$atext$$btxt$$2rdacontent
000046742 337__ $$aunmediated$$bn$$2rdamedia
000046742 338__ $$avolume$$bnc$$2rdacarrier
000046742 516__ $$aOnline publication.
000046742 520__ $$a本文件由世界知识产权组织仲裁与调解中心 （产权组织中心）编写，是世界知识产权组织（产权组织）为成员国提供的针对 2019 新型冠状病毒的支持方案的一部分。本文件考虑到了制药及 生命科学协会、部门专家以及产权组织仲裁员和调解员 的意见。
000046742 650_0 $$aIntellectual property.
000046742 650_4 $$aAlternative Dispute Resolution
000046742 7102_ $$aWorld Intellectual Property Organization
000046742 77418 $$aAMC
000046742 85648 $$3Abstract with links to full text$$uhttps://dx.doi.org/10.34667/tind.46742
000046742 8564_ $$y10.34667/tind.46742$$982167459-9c69-4d82-baf3-a6e5ac3d7be8$$s706865$$uhttps://tind.wipo.int/record/46742/files/wipo-pub-rn2022-14-zh-wipo-adr-options-for-life-sciences-dispute-management-and-resolution.pdf
000046742 901__ $$aWIPO/PUB/RN2022/14
000046742 902__ $$a46742_zh
000046742 904__ $$aBook
000046742 909__ $$ooai:tind.wipo.int:46742$$pWIPOPUB
000046742 909CO $$ooai:tind.wipo.int:46742$$pWIPOPUB
000046742 980__ $$aWIPOPUB